Iressa Activity Not Likely Predicted By EGFR Expression Level – AstraZeneca

The level of EGFR expression seen in solid tumors is not a likely predictor of clinical activity observed with Iressa, AstraZeneca Iressa Global Product Director Linda Summerton said Nov. 7